Making Sense of Inhibiting Nonsense in Hypertrophic Cardiomyopathy

Affiliations

¹ Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg, Germany. German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Germany.

Editorial

Lucie Carrier. Circulation. 2019.

. 2019 Feb 5;139(6):812-814.

doi: 10.1161/CIRCULATIONAHA.118.037936.

¹ Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg, Germany. German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Germany.

No abstract available

Keywords: Editorials; autophagy; cardiomyopathy, hypertrophic; myocytes, cardiac; proteasome inhibitors; regeneration.

Comment on

A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
Seeger T, Shrestha R, Lam CK, Chen C, McKeithan WL, Lau E, Wnorowski A, McMullen G, Greenhaw M, Lee J, Oikonomopoulos A, Lee S, Yang H, Mercola M, Wheeler M, Ashley EA, Yang F, Karakikes I, Wu JC. Seeger T, et al. Circulation. 2019 Feb 5;139(6):799-811. doi: 10.1161/CIRCULATIONAHA.118.034624. Circulation. 2019. PMID: 30586709 Free PMC article.